No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs528390995 |
chr4:119339045-119339046 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs535436855 |
chr4:119339058-119339059 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs370944618 |
chr4:119339133-119339134 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs188393653 |
chr4:119339166-119339167 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs541699182 |
chr4:119339181-119339182 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs1828857 |
chr4:119339182-119339183 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs1808022 |
chr4:119339208-119339209 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs556894418 |
chr4:119339222-119339223 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs1828856 |
chr4:119339227-119339228 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs530909226 |
chr4:119339336-119339337 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs3896922 |
chr4:119339345-119339346 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs546352195 |
chr4:119339367-119339368 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs553393316 |
chr4:119339458-119339459 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs573320721 |
chr4:119339484-119339485 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs542246312 |
chr4:119339499-119339500 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs4103597 |
chr4:119339515-119339516 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs3879776 |
chr4:119339569-119339570 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs71608371 |
chr4:119339691-119339692 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs531124020 |
chr4:119339767-119339768 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs544761463 |
chr4:119339913-119339914 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs564550691 |
chr4:119339923-119339924 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs532064782 |
chr4:119339950-119339951 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs4103612 |
chr4:119340054-119340055 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs565335863 |
chr4:119340062-119340063 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs570529012 |
chr4:119340064-119340065 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs528034062 |
chr4:119340077-119340078 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs533190988 |
chr4:119340139-119340140 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs574863506 |
chr4:119340163-119340164 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs181218832 |
chr4:119340164-119340165 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs4001535 |
chr4:119340192-119340193 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs568311096 |
chr4:119340203-119340204 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs4001536 |
chr4:119340269-119340270 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
33 |
rs536136800 |
chr4:119340287-119340288 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs549321029 |
chr4:119340318-119340319 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs569387784 |
chr4:119340321-119340322 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs557098596 |
chr4:119340399-119340400 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs570594333 |
chr4:119340403-119340404 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs200318414 |
chr4:119340470-119340471 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs71608374 |
chr4:119340504-119340505 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
40 |
rs185721854 |
chr4:119340511-119340512 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs71608375 |
chr4:119340514-119340515 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
42 |
rs573383062 |
chr4:119340518-119340519 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs535811268 |
chr4:119340553-119340554 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs1843662 |
chr4:119340679-119340680 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs576989188 |
chr4:119340691-119340692 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs4001513 |
chr4:119340692-119340693 |
Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs544615123 |
chr4:119340718-119340719 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs200844818 |
chr4:119340740-119340741 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs202009712 |
chr4:119340785-119340786 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs4001514 |
chr4:119340806-119340807 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|